Patent Law Update: Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company
NEWS -Patent Law Update: Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company
Patent Law Update: Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company
Timothy C. Meece co-authors an article on TS Tech
D.C. Bar Sections Council Chair and Strategic Planning Committee member, Darrell G. Mottley, helped develop the First Strategic Plan for the D.C Bar. The First Strategic Plan was adopted by
Fraser D. Brown and John P. Iwanicki author a guest column on Bilski v. Kappos
Robert H. Resis’s article on Post-KSR Pharmaceutical Obviousness is published in Landslide
Helen Hill Minsker authors a guest column for Chicago Lawyer magazine
Sarah Kagan authors a guest column on Prometheus Laboratories, Inc. v Mayo Collaborative Services
Marc S. Cooperman’s monthly column on IP issues affecting the toy and game industry
Bradley C. Wright comments on the Bilski Oral Argument in BNA’s Patent, Trademark and Copyright Law Daily
Bradley C. Wright comments on the Bilski Oral Argument in Managing Intellectual Property